Drug Type Mesenchymal stem cell therapy |
Synonyms- |
Target |
Action modulators |
Mechanism NIS modulators(solute carrier family 5 member 5 modulators) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 2/3 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Huntington Disease | Phase 3 | Brazil | 10 Feb 2020 |